The Role of Cyclooxygenase Products in the Acute Airway Obstruction and Airway Hyperreactivity of Ponies with Heaves
- 1 July 1989
- journal article
- research article
- Published by American Thoracic Society in American Review of Respiratory Disease
- Vol. 140 (1) , 154-160
- https://doi.org/10.1164/ajrccm/140.1.154
Abstract
Airway obstruction and hyperreactivity are characteristics off human asthma and of “heaves,” a naturally occurring respiratory disorder of horses and ponies. To document the role of cyclooxygenase products of arachidonic acid metabolism in the pathogenesis of heaves, we measured plasma and bronchoalveolar lavage (BAL) fluid concentrations of metabolites of thromboxane (TX)A2 and prostaglandins (PG) I2 and D2 in five affected ponies and their age- and gender-matched controls prior to and during acute airway obstruction precipitated by housing the ponies in a barn and exposing them to hay dust. Pulmonary resistance increased significantly and dynamic compliance and arterial oxygen tension decreased significantly in affected ponies that were placed in the barn. At this time, histamine aerosol challenge demonstrated the presence of airway hyperresponsiveness in the affected ponies. Plasma TXB2 was the only metabolite that increased significantly during the acute disease state. In a subsequent experiment, the ponies were treated with flunixin meglumine, a cyclooxygenase inhibitor, to determine if this would alter the onset or development of clinical disease. At a dose of 1.1 mg/kg intramuscularly, 3 times daily, flunixin meglumine inhibited TXB2 production but did not alter the degree of airway obstruction or airway hyperreactivity measured at pasture and in the barn. We conclude that cyclooxygenase products of arachidonic acid metabolism are altered but do not play a role in the airway obstruction and hyperreactivity observed in ponies with heaves.This publication has 9 references indexed in Scilit:
- Enhancement of leukotriene D4-induced contraction of guinea-pig isolated trachea by platelet activating factorProstaglandins, 1987
- Effects of a thromboxane synthetase inhibitor (OKY-046) and a lipoxygenase inhibitor (AA-861) on bronchial responsiveness to acetylcholine in asthmatic subjects.Thorax, 1986
- Transformation of prostaglandin D2 to 9 alpha, 11 beta-(15S)-trihydroxyprosta-(5Z,13E)-dien-1-oic acid (9 alpha, 11 beta-prostaglandin F2): a unique biologically active prostaglandin produced enzymatically in vivo in humans.Proceedings of the National Academy of Sciences, 1985
- A new plasma source based on contact ionizationJournal of Applied Physics, 1985
- Airway reactivity in ponies with recurrent airway obstruction (heaves)Journal of Applied Physiology, 1985
- Leukotriene B4: An inflammatory mediator In vivoProstaglandins, 1981
- Bronchospasm and pressor effects induced in the guinea-pig by leukotriene C4 are probably due to release of cyclooxygenase productsEuropean Journal of Pharmacology, 1981
- Asthma Improved by Nonsteroidal Anti-Inflammatory DrugsAnnals of Internal Medicine, 1978
- Bronchial Asthma Induced by IndomethacinAnnals of Internal Medicine, 1967